Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
News
With CDC vaccine guidance effectively on pause, top medical groups take matters into their own hands. AAFP, AAP, ACOG, and IDSA released evidence-based recommendations for flu, COVID-19, and RSV vaccines for the 2026-27 respiratory season, backed by an independent review of hundreds of peer-reviewed studies. The bottom line: vaccines still work, and no new safety concerns were found.
With the CDC's immunization recommendations effectively paused for nearly five months, four major medical organizations — AAFP, AAP, ACOG, and IDSA — stepped up to fill the void. On Wednesday, they released evidence-based vaccine guidance for the 2026-27 respiratory season covering flu, COVID-19, and RSV, backed by an independent review from the Vaccine Integrity Project (VIP), a CIDRAP initiative at the University of Minnesota.
The VIP reviewed hundreds of peer-reviewed studies published since August 2025 and found that vaccines continue to provide meaningful protection against severe illness, hospitalization, and death — with no new safety concerns identified. The reviews were simultaneously published in JAMA. The AMA also launched SpreadTheFacts.org, a centralized digital hub with immunization resources for both clinicians and patients.
Key Takeaways:
Why it matters: The breakdown of the federal vaccine guidance process has left clinicians, parents, and patients without a clear, trusted source of immunization advice heading into respiratory virus season. This independent effort aims to restore that confidence with transparent, science-driven recommendations.
